฿
1.75
Jul 16
Business Description
Chiang Mai Ram Medical Business PCL
ISIN : TH0432010Z05
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 0.88 | |||||
Debt-to-EBITDA | 3.07 | |||||
Interest Coverage | 3.12 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.38 | |||||
Beneish M-Score | -2.97 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.1 | |||||
3-Year EBITDA Growth Rate | 19.1 | |||||
3-Year EPS without NRI Growth Rate | -5.7 | |||||
3-Year Book Growth Rate | 6.2 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 20.68 | |||||
9-Day RSI | 28.11 | |||||
14-Day RSI | 29.99 | |||||
6-1 Month Momentum % | -9.62 | |||||
12-1 Month Momentum % | -22.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.35 | |||||
Quick Ratio | 0.31 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 10.96 | |||||
Days Sales Outstanding | 17.18 | |||||
Days Payable | 28.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.07 | |||||
Dividend Payout Ratio | 1.31 | |||||
3-Year Dividend Growth Rate | 3.8 | |||||
Forward Dividend Yield % | 3.07 | |||||
5-Year Yield-on-Cost % | 4.23 | |||||
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | 7.53 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 23.46 | |||||
Operating Margin % | 9.31 | |||||
Net Margin % | 4.68 | |||||
FCF Margin % | 12.13 | |||||
ROE % | 5.51 | |||||
ROA % | 1.88 | |||||
ROIC % | 2.64 | |||||
ROC (Joel Greenblatt) % | 9.46 | |||||
ROCE % | 6.95 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 30.17 | |||||
PE Ratio without NRI | 41.67 | |||||
Shiller PE Ratio | 17.53 | |||||
PEG Ratio | 4.48 | |||||
PS Ratio | 1.37 | |||||
PB Ratio | 1.77 | |||||
Price-to-Tangible-Book | 1.92 | |||||
Price-to-Free-Cash-Flow | 11.36 | |||||
Price-to-Operating-Cash-Flow | 7.32 | |||||
EV-to-EBIT | 15.83 | |||||
EV-to-EBITDA | 8.96 | |||||
EV-to-Revenue | 2 | |||||
EV-to-FCF | 16.77 | |||||
Price-to-Projected-FCF | 1.58 | |||||
Price-to-DCF (Earnings Based) | 3.65 | |||||
Price-to-DCF (FCF Based) | 0.98 | |||||
Price-to-Median-PS-Value | 0.52 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.24 | |||||
Price-to-Graham-Number | 1.88 | |||||
Earnings Yield (Greenblatt) % | 6.32 | |||||
FCF Yield % | 8.8 | |||||
Forward Rate of Return (Yacktman) % | 13.89 |